[Central hypothyroidism related with bexarotene treatment].
Sucunza
Nuria
N
García-Muret
M Pilar
MP
Rodríguez
José
J
Corcoy
Rosa
R
D016588:Anticarcinogenic Agents / Q000009:adverse effects*; D000077610:Bexarotene; D005260:Female; D006801:Humans; D007037:Hypothyroidism / Q000139:chemically induced*; D008875:Middle Aged; D013764:Tetrahydronaphthalenes / Q000009:adverse effects*
D016588:Anticarcinogenic Agents; D013764:Tetrahydronaphthalenes; D000077610:Bexarotene